Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News iShares US Pharmaceuticals ETF IHE

The investment seeks to track the investment results of the Dow Jones U. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical... see more

Recent & Breaking News (ARCA:IHE)

    BlackRock Announces Product Updates to 10 iShares ETFs

    Business Wire December 21, 2023

    Last Night's Election - A Series Of Fortunate Events For Big Pharma

    Benzinga.com  November 9, 2016

    ETF Week Ahead Preview: Hoping For No November Rain

    Benzinga.com  November 2, 2015

    These ETFs Should Love The Pfizer-Allergan News

    Benzinga.com  October 29, 2015

    Oregon cannabis extraction company set to list on CSE as state okays recreational use

    Canadian Press, with file by Stockhouse October 1, 2015

    Canadian company charged in the U.S. with selling unapproved, counterfeit drugs

    Canadian Press August 11, 2015

    CVS to snap up Omnicare for $10.4 billion in bid to enter senior care

    Canadian Press May 21, 2015

    Johnson & Johnson seeks to boost drug profits with slew of product submissions

    Canadian Press May 20, 2015

    True Leaf Medicine (C.MJ) starts the production wheels turning

    Stockhouse Editorial May 6, 2015

    FDA drug approvals hit highest levels in almost 20 years

    Canadian Press January 2, 2015

    Can Small Caps Regain Their Footing Soon?

    Equities.com May 21, 2014

    Gallant Pharma founder gets 3-year prison term for misbranded drugs

    Canadian Press May 10, 2014

    Oregon regulators say no to marijuana-based baked goods

    Canadian Press March 20, 2014

    Zogenix (ZGNX) jumps 36% as FDA snubs own panel to approve stronger hydrocodone

    Canadian Press October 25, 2013